The Treatment of Thyroid Cancer With Radiofrequency Ablation

Tech Vasc Interv Radiol. 2022 Jun;25(2):100825. doi: 10.1016/j.tvir.2022.100825. Epub 2022 Mar 10.

Abstract

In the past decade, there has seen been a shift from treating all thyroid cancer surgically, to favoring less aggressive approaches for low-risk thyroid cancer. Surgery was historically the treatment of choice for most thyroid cancer. Active surveillance has emerged as an alternative for low-risk thyroid cancer in select patients. This approach has been accepted worldwide, and sound evidence supports its oncological safety in carefully selected patients. However, not all patients want to undergo lifelong monitoring, and some patients may wish to treat their cancer in a minimally invasive manner. Thermal ablation has developed as a minimally invasive alternative to surgery and active surveillance for well selected patients with thyroid malignancy. Herein, we review the role of thermally ablative techniques, specifically radiofrequency ablation, for the treatment of small primary thyroid cancers, recurrent thyroid cancer, and lymph node metastases.

Keywords: lymph node metastases; radiofrequency ablation; recurrent thyroid cancer; thermal ablation; thyroid cancer.

Publication types

  • Review

MeSH terms

  • Catheter Ablation* / adverse effects
  • Humans
  • Neoplasm Recurrence, Local / surgery
  • Radiofrequency Ablation* / adverse effects
  • Thyroid Neoplasms* / diagnostic imaging
  • Thyroid Neoplasms* / pathology
  • Thyroid Neoplasms* / surgery
  • Treatment Outcome